eqix posts

Feed

Closing Bell: When Confusion Leads (AAPL, VZ, CSCO, COST, EQIX, JASO, MON, CRM)

Today was a mixed day where traders and investors alike could not decide whether to trade cautiously or whether to take on risk again. More technology concerns were prevalent and the newest jobs data led traders to believe that the non-Farm payrolls data will come in weaker on Friday.

Here were today's unofficial closing bell levels:

Dow Jones 10,967.65 +22.93 (0.21%)
S&P 500 1,159.97 -0.78 (-0.07%)
Nasdaq 2,380.66 -19.17 (-0.80%)

Continue reading Closing Bell: When Confusion Leads (AAPL, VZ, CSCO, COST, EQIX, JASO, MON, CRM)

Analyst Calls: VIA, CMA, PRU, CMG, PBR, TXN, DHR, HUM

Analyst upgrades:
  • Citigroup upgraded Lubrizol (LZ) to Hold from Sell following the company's analyst day citing its continued pricing power in lubricants. Citi upped its target price for shares to $115 from $82.
  • Janney Montgomery upgraded Viacom (VIA) to Buy from Neutral citing the company's ratings improvement, 2011 film slate, and video game pipeline. The firm has a $45 price target for shares.
  • BMO Capital resumed coverage on Gammon Gold (GRS) with an Outperform from a Market Perform following the its equity issue. The firm has a $12.50 price target on the stock.
  • Comerica (CMA) and First Horizon (FHN) were upgraded to Buy from Hold at Deutsche Bank.
  • Prudential (PRU) was upgraded to Equal Weight from Underweight at Barclays.
  • Itron (ITRI) was upgraded to Hold from Sell at Stifel Nicolaus.

Continue reading Analyst Calls: VIA, CMA, PRU, CMG, PBR, TXN, DHR, HUM

Analyst Calls: ACI, BA, COP, CTXS, CVS, NGS, NVDA, VPRT, WSM ...

Analyst Upgrades

  • BofA/Merrill upgraded ConocoPhillips (COP) to neutral from underperform following the better-than-expected Q2 report. The firm has a $61 price target on shares.
  • Deutsche Bank upgraded Citrix Systems (CTXS) to buy from hold following the company's Q2 results and raised its target for shares to $65 from $45. Shares were also upgraded to neutral from underperform at Cowen following the better-than-expected Q2 report.
  • Macquarie upgraded Arch Coal (ACI) to outperform from underperform and raised its price target to $29 from $23. The firm expects PRB priced to move higher given increased domestic and export demand combined with supply shortfalls.
  • Boeing (BA) was upgraded to hold from sell at Societe Generale.
  • Equinix (EQIX) was upgraded to outperform from perform at Oppenheimer.
  • Williams-Sonoma (WSM) was upgraded to equal weight from underweight at Barclays.

Continue reading Analyst Calls: ACI, BA, COP, CTXS, CVS, NGS, NVDA, VPRT, WSM ...

Analyst Calls: CCRT, DKS, HAST, JCP, M, MTG, MUSA, TJX, VZ, WWE ...

Analyst Upgrades

  • Needham upgraded Dick's Sporting Goods (DKS) to buy from hold following the company's Q1 results as it believes the sell-off in shares provides an attractive entry point into the name. The firm has a $31 price target for the stock. Piper Jaffrey upgraded Dick's Sporting to overweight from neutral following the company's Q1 results and raised its target for shares to $34 from $31.
  • Piper Jaffray also upgraded MGIC Investment (MTG) to overweight from neutral. The firm upgraded shares on valuation and raised its target to $11 from $10.
  • Macy's (M) was upgraded to buy from neutral and VeriSign (VRSN) was upgraded to sell from conviction sell at Goldman.
  • Fidelity National (FIS) was upgraded to outperform from market perform at Raymond James.
  • Watson Pharma (WPI) was upgraded to overweight from neutral at JPMorgan.

Continue reading Analyst Calls: CCRT, DKS, HAST, JCP, M, MTG, MUSA, TJX, VZ, WWE ...

Analyst Calls: AA, ALK, FYSIS, LAMR, LEAP, LVS, MSFT, PCLN, RIG, UHS ...

Analyst Upgrades

  • Wells Fargo upgraded Universal Health (UHS) to outperform from market perform to reflect the company's potential acquisition of Psychiatric Solutions (PSYS). The firm sees a 60% chance of Universal Health acquiring Psychiatric Solutions and estimates the deal would be accretive.
  • Oppenheimer upgraded Lamar Advertising (LAMR) to outperform from perform following the company's Q1 results and Q2 guidance as it expects growth to pick up in Q3. The firm has a $44 price target for shares.
  • UBS upgraded Las Vegas Sands (LVS) to buy from neutral based on valuation and Singapore outlook. The firm raised its price target to $28 from $24.
  • Priceline.com (PCLN) was upgraded to buy from hold at ThinkEquity.
  • Alcoa (AA) Was upgraded to outperform from market perform at BMO Capital.
  • Brookfield Asset Management (BAM) was upgraded to outperform from neutral at Credit Suisse.

Continue reading Analyst Calls: AA, ALK, FYSIS, LAMR, LEAP, LVS, MSFT, PCLN, RIG, UHS ...

Top Picks for 2010: Equinix (EQIX)

This post is part of a special report, Top Picks for 2010, the 27th annual survey in which TheStockAdvisors.com asks the nation's leading advisors for their single favorite stock for the new year. See all 80 stocks listed here.

"Equinix (EQIX), the global data center operator, is one of the most tempting growth stock opportunities on the 2010 horizon," says Stephen Quickel.

The editor of US Investment Report explains, "Big banks, market data providers, telecoms and other technology-driven clients use the firm's data center platforms to reduce their own capital expenditures and operating costs."

Continue reading Top Picks for 2010: Equinix (EQIX)

Analyst upgrades, downgrades and initiations: ABT, BA, CLWR, LLY, LTD, NFLX ...

Analyst upgrades:

  • Stephens upgraded Quidel (QDEL) to equal weight from underweight on valuation following the recent pullback in shares. The firm keeps a $16 price target on the stock.
  • UBS upgraded Clearwire (CLWR) to neutral from sell, citing the company's funding, which increases opportunities. The firm raised its price target to $6 from $3.
  • Oppenheimer upgraded Mattson Technology (MTSN) to outperform from perform on expectations the company will benefit from a cyclical recovery in memory capex spending in 2010. The firm raised its target on shares to $4 from $3.
  • Eli Lilly (LLY) was upgraded to sell from conviction sell at Goldman.
  • Kinross Gold (KGC) was upgraded to overweight from neutral at JPMorgan.
  • Limited Brands (LTD) was upgraded to hold from sell at Soleil.

Continue reading Analyst upgrades, downgrades and initiations: ABT, BA, CLWR, LLY, LTD, NFLX ...

Analyst upgrades, downgrades and initiations: FCX, MOT, CHK, MON ...

Analyst upgrades:
  • Deutsche Bank upgraded Freeport McMoRan (NYSE: FCX) to Buy from Hold to reflect the company's better than expected Q3 results and improved volume outlook. Deutsche raised its target on shares to $100 from $72.
  • Thomas Weisel upgraded Motorola (NYSE: MOT) to Overweight from Market Weight and raised its target to $11 from $7 and said they expect Motorola to benefit from several upcoming catalysts that include new Android-based smartphone products and they believe the handset division could break even by year end of 2010.
  • Janney Montgomery upgraded Regal Entertainment (NYSE: RGC) and Cinemark (NYSE: CNK) to Buy from Neutral on expectations both companies will benefit from a strong box office in Q4. The firm has a $14 price target on Regal shares and a $13.50 target on Cinemark shares.
  • Marshall & llsley (NYSE: MI) was upgraded to Neutral from Underweight at JPMorgan.
  • F5 Networks (NASDAQ: FFIV) was upgraded to Neutral from Sell at UBS.
  • William Blair upgraded Lindsay Corporation (NYSE: LNN) to Outperform from Market Perform.

Continue reading Analyst upgrades, downgrades and initiations: FCX, MOT, CHK, MON ...

Analyst upgrades, downgrades and initiations: ALU, BJ, CPB, KMX, PGR

Analyst Upgrades
  • McAdams Wright expects Dendreon's (NASDAQ: DNDN) near-term momentum to continue but has long-term concerns that Street estimates are too high. The firm upgraded shares to Hold from Sell.
  • JPMorgan upgraded Ameristar Casinos (NASDAQ: ASCA) to Overweight from Neutral to reflect valuation, potential catalysts from Colorado's easing gaming regulations, and the company's strong free cash flow. The firm raised its target on shares to $24 from $20.
  • Citigroup upgraded Valspar (NYSE: VAL) to Hold from Sell after channel checks indicated paint demand is shifting to big-box retailers, the company's primary sales channel. The firm raised its target on shares to $22 from $19.
  • Vulcan Materials (NYSE: VMC) was upgraded to Buy from Neutral at UBS.
  • Altera (NASDAQ: ALTR) was raised to Outperform from Sector Perform at RBC Capital.
  • Spectra Energy (NYSE: SEP) was upgraded to Neutral from Sell at Goldman.

Continue reading Analyst upgrades, downgrades and initiations: ALU, BJ, CPB, KMX, PGR

Analyst upgrades, downgrades and initiations: CI, CCE, JBLU, LIZ, LLL

Analyst upgrades:

  • Oppenheimer upgraded FTI Consulting (NYSE:FCN) to Outperform from Perform on expectations the stock will outperform in the second half of 2009 due to easier comparisons and a "deeper and longer" restructuring cycle. The firm has a $62 target on shares.
  • Citigroup upgraded Cigna (NYSE:CI) to Hold from Sell to reflect reduced balance sheet risk following the company's capital raise and the potential for a PBM sale. The firm raised its target price to $23 from $13.
  • Goldman expects Coca-Cola Enterprises (NYSE:CCE) to benefit from favorable soda demand and lower commodity costs. The firm upgraded shares to Conviction Buy from Buy and has a $20 target on the stock.
  • Novellus (NASDAQ:NVLS) was raised to Buy from Neutral at Bank of America/Merrill.
  • CME Group (NASDAQ:CME) was upgraded at JP Morgan to Neutral from Underweight.
  • Allegiant (NASDAQ:ALGT) was upgraded to Overweight from Equal Weight at Morgan Stanley.

Continue reading Analyst upgrades, downgrades and initiations: CI, CCE, JBLU, LIZ, LLL

Analyst upgrades, downgrades and initiations: QCOM, AAPL, IBM, BP, MS, VMW, TVA ...

Analyst upgrades:
  • Jefferies upgraded Brocade (NASDAQ: BRCD) to Buy from Hold on expectations expanding OEM partnerships, new products and entry into new markets will drive long-term growth. The firm's channel checks indicate the first phase of an IBM (NYSE: IBM) deal for ethernet products will be announced next week. Jefferies raised its target price on the stock to $6 from $3.50.
  • JMP Securities upgraded Broadcom (NASDAQ: BRCM) to Market Perform from Underperform citing the potential settlement with Qualcomm (NASDAQ: QCOM). The firm said Broadcom has far more to gain than Qualcomm has to lose.
  • Citigroup upgraded Air Products (NYSE: APD) and Praxair (NYSE: PX) to Buy from Hold on expectations that an improvement in customer operating rates will benefit gas companies. The firm raised its target price on Air Products to $70 from $55 and on Praxair to $79 from $63.
  • Royal Bank of Scotland upgraded BP Plc (NYSE: BP) to Buy from Hold to reflect its dividend yield at current levels.
  • Apple (NASDAQ: AAPL) was raised to Outperform from Underperform at RBC Capital.
  • T. Rowe Price (NYSE: TROW) was upgraded at Sandler O'Neill to Hold from Sell.
  • Morgan Stanley (NYSE: MS) was lifted to Neutral from Underperform at Banc of America/Merrill.

Continue reading Analyst upgrades, downgrades and initiations: QCOM, AAPL, IBM, BP, MS, VMW, TVA ...

Analyst upgrades, downgrades and initiations: MSFT, AXP, RBS, FIATY, NFLX ...

Analyst upgrades:
  • RBC Capital believes software stock fundamentals have bottomed and that the next several quarters should see reduced earnings risk, easier comps, stimulus spending benefits, and lower FX headwinds. The firm upgraded Microsoft (NASDAQ: MSFT), Taleo (NASDAQ: TLEO), Digital River (NASDAQ: DRIV) and Symantec (NASDAQ: SYMC) to Outperform from Sector Perform.
  • Rodman & Renshaw upgraded Provectus (OTC: PVCT) to Outperform from Market Perform. The firm has increased conviction in the success of the company's ongoing trial of PV-10 in melanoma.
  • Citigroup upgraded shares of American Express (NYSE: AXP) to Hold from Sell as it believes the risk/reward is balanced at current levels and that there are signs of potential credit market stabilization. The firm raised its price target on shares to $16 from $9.
  • Brinker (NYSE: EAT) was upgraded to Outperform from Market Perform at Wachovia.
  • PG&E (NYSE: PCG) was raised to Outperform from Neutral at Credit Suisse.
  • Federal-Mogul (NASDAQ: FDML) was lifted to Conviction Buy from Buy at Goldman.

Continue reading Analyst upgrades, downgrades and initiations: MSFT, AXP, RBS, FIATY, NFLX ...

Analyst upgrades: KO, NVO, EQIX, PETM, URBN

MOST NOTEWORTHY: Coca-Cola, Novo Nordisk and Equinix were today's noteworthy upgrades:
  • Bear Stearns upgraded The Coca-Cola Company (NYSE: KO) to Outperform from Peer Perform, as they expect it to post solid earnings short-term with potential upside, and over the long-term due to its upgraded business model.
  • Bernstein raised its rating on Novo Nordisk AS (NYSE: NVO) to Outperform from Market Perform, as they believe consensus estimates do not reflect the company's growth potential.
  • Merriman upgraded shares of Equinix Inc (NASDAQ: EQIX) to Buy from Neutral on valuation following the recent sell-off. The firm expects strong Q4 results.
OTHER UPGRADES:

Analyst initiations: Linc Energy, Equinix, Smith & Wesson

MOST NOTEWORTHY: Linc Energy, Equinix and Smith & Wesson were today's noteworthy initiations:
  • Merriman initiated Linc Energy (OTC: LNCGY) with a Buy rating and believes the company is well-positioned to become a large producer of ultra-clean, high quality diesel fuel, at extremely high margins.
  • Equinix (NASDAQ: EQIX) was assumed with a Buy rating and $120 target at Deutsche Bank. The firm thinks the company continues to benefit from favorable industry dynamics as customer demand continues to outstrip supply of new co-location space industry-wide.
  • Susquehanna is positive on Smith & Wesson's (NASDAQ: SWHC) leading market position in the handgun market and top line growth. The firm started shares with a Positive rating.
OTHER INITIATIONS:

Analyst initiations: GSK, EQIX and CVG

MOST NOTEWORTHY: GlaxoSmithKline, Equinix and Convergys were today's noteworthy initiations:
  • Societe Generale believes consensus estimates are underestimating the quality of GlaxoSmithKline's (NYSE: GSK) base business. The firm started shares with a Buy rating.
  • Merriman believes Equinix's (NASDAQ: EQIX) data center footprint leaves it highly exposed to changing market dynamics, including virtualization, and initiated shares with a Neutral rating. They see limited upside over the next 12 months.
  • Convergys (NYSE: CVG) was reinstated with a Hold rating and $19 target at Kaufman Bros, as they are not confident in the company's 2008 new signings outlook and is concerned that the current restructuring and headcount cuts will prove disruptive over the medium term.
OTHER INITIATIONS:
  • First Solar (NASDAQ: FSLR) was initiated with a Buy rating and $360 target at UBS.
  • Wachovia resumed coverage of News Corp (NYSE: NWS) with a Market Perform rating.
  • Baird initiated Sealed Air (NYSE: SEE) with a Neutral rating.

Next Page >

Symbol Lookup
IndexesChangePrice
DJIA-89.2312,801.23
NASDAQ-23.352,903.88
S&P 500-9.311,342.64

Last updated: February 11, 2012: 12:20 AM

Hot Stocks

General Electric

18.875-0.255(-1.33)

Alcoa

10.29-0.35(-3.29)

Apple Inc

493.42+0.25(+0.05)

Google Inc 'A'

605.91-5.55(-0.91)

Bank of America

8.07-0.11(-1.34)

Wal-Mart Stores

61.90-0.06(-0.10)

Exxon Mobil Corp

83.80-1.08(-1.27)

Ford

12.44-0.25(-1.97)

Citigroup

32.925-0.735(-2.18)

IBM

192.42-0.71(-0.37)

Yahoo

16.14+0.14(+0.88)

Starbucks

48.82-0.38(-0.77)

Microsoft

30.495-0.275(-0.89)

Home Depot

45.33+0.06(+0.13)

DailyFinance Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

Page Loaded in 1328937633737 ms.